It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Neisseria lactamica is a harmless coloniser of the infant respiratory tract, and has a mutually-excluding relationship with the pathogen Neisseria meningitidis. Here we report controlled human infection with genomically-defined N. lactamica and subsequent bacterial microevolution during 26 weeks of colonisation. We find that most mutations that occur during nasopharyngeal carriage are transient indels within repetitive tracts of putative phase-variable loci associated with host-microbe interactions (pgl and lgt) and iron acquisition (fetA promotor and hpuA). Recurrent polymorphisms occurred in genes associated with energy metabolism (nuoN, rssA) and the CRISPR-associated cas1. A gene encoding a large hypothetical protein was often mutated in 27% of the subjects. In volunteers who were naturally co-colonised with meningococci, recombination altered allelic identity in N. lactamica to resemble meningococcal alleles, including loci associated with metabolism, outer membrane proteins and immune response activators. Our results suggest that phase variable genes are often mutated during carriage-associated microevolution.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Laver, Jay R 1 ; Gorringe, Andrew 3 ; Deasy, Alice M 4 ; Dale, Adam P 5 ; Morris, Paul D 4 ; Didelot, Xavier 6 ; Maiden, Martin C J 7
; Read, Robert C 2
1 Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK
2 Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK; Southampton NIHR Biomedical Research Centre, University Hospital Southampton, Southampton, UK; Institute for Life Sciences, University of Southampton, Southampton, UK
3 Public Health England, Porton Down, Salisbury, UK
4 Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, UK; Department of Cardiology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK
5 Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK; Southampton NIHR Biomedical Research Centre, University Hospital Southampton, Southampton, UK
6 School of Public Health, Faculty of Medicine, Imperial College London, London, UK; Department of Statistics, School of Life Sciences, Gibbet Hill Campus, University of Warwick, Coventry, UK
7 Department of Zoology, Peter Medawar Building, University of Oxford, Oxford, UK




